Ochsner Multi-Organ Transplant Institute Named No. 1 In The Nation For Liver Transplants
NEW ORLEANS, Jan. 28, 2013 /PRNewswire/ -- CareChex, a division of The Delta Group specializing in rating the quality of hospital and physician care, has named the Ochsner Multi-Organ Transplant Institute number one in the country for liver transplants in its 2013 Hospital ratings. This prestigious distinction recognizes Ochsner as the top hospital in the nation out of over 100 hospitals rated for liver transplants.
The CareChex Medical Quality Rating System provides a comprehensive, multi-dimensional analysis of medical quality. It incorporates multiple peer-reviewed methodologies which specifically address key components of the quality of inpatient care. The methods for the clinical category of Liver Transplant encompass the following quality measures:
- Patient Safety Indicators
- Mortality Rates
- Complication Rates
"Receiving this recognition is a true testament to our innovation and dedication to excellence we have instituted since inception," said George Loss, Jr., MD, PhD, FACS, System Chair, Department of Surgery, Chief of Ochsner Multi-Organ Transplant Institute. "Our ability to research new technologies and procedures prepares us to meet the future needs of patients from across the country.""CareChex allows the public to make informed decisions regarding the quality of medical and surgical care provided by hospitals," said Dr. Thane Forthman, managing principal at The Delta Group. "We are pleased to acknowledge that Ochsner has achieved an exceptionally high level of performance, especially in the area of medical excellence for Liver Transplants. Ochsner is a benchmark that other hospitals should seek to emulate." Ochsner's comprehensive team consists of transplant surgeons, physicians and support specialists who have performed more than 4,500 liver, pancreas, kidney, heart and lung transplants. In 2012, more than 2,900 patients were referred to Ochsner as potential transplant candidates and 356 of those transplant procedures were performed. "Our team uses a multi-disciplinary approach across the entire system which contributes to our transplant successes," said Nigel Girgrah, MD, PhD, Head of Hepatology, Medical Director of the Multi-Organ Transplant Institute. "This accolade is further proof that we have the right people and processes in place to provide high quality care for these patients."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts